Aggressive debridement and early antifungal therapy in the management of cutaneous mucormycosis: A case report with review of literature

Authors

  • Sebin Sebastian Sebastian
  • Pushependra Malik
  • Chanderbhan Bhan
  • M K Garg
  • Prakash Raj Ujjalsingh

DOI:

https://doi.org/10.32677/ijcr.vi.4318

Keywords:

Aggressive antifungal therapy, Coronavirus disease-19, Cutaneous mucormycosis, Early debridement

Abstract

Mucormycosis is an infectious disease caused by fungi. The worldwide spread of coronavirus disease-19 did create a public health crisis, infecting millions of people and causing huge numbers of deaths worldwide. Cutaneous manifestations of mucormycosis can either be primary or secondary diseases. Clinical manifestations can vary from cellulitis, abscess, or ulcer. Standard management includes early diagnosis, surgical debridement, and antifungal therapy. Early initiation of antifungal therapy can lower mortality rates and improve the prognosis of patients. The estimated mortality ranges from 25% to 87%, depending on the site of infection.

Downloads

Download data is not yet available.

Downloads

Published

2024-03-01

Issue

Section

Case Report

How to Cite

Aggressive debridement and early antifungal therapy in the management of cutaneous mucormycosis: A case report with review of literature. (2024). Indian Journal of Case Reports, 10(2), 35-37. https://doi.org/10.32677/ijcr.vi.4318

Most read articles by the same author(s)

<< < 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 > >>